A Study of the Relative Bioavailability of ASC18 Tablets vs Reference Tablets in Healthy Volunteers
Clinical trial NCT04358523 · COMPLETED
Trial details
- NCT number
- NCT04358523
- Sponsor
- Ascletis Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-20
- Primary completion
- 2020-12-15
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.